Literature DB >> 3734746

3-Methoxytyramine in the putamen as a gauge of the postmortem interval.

D L Sparks, J T Slevin, J C Hunsaker.   

Abstract

The armamentarium of the forensic thanatologist includes the examiner's subjective assessment of bodily changes together with comprehensive evaluation of environmental and associated factors to estimate the postmortem interval (PMI). Of the various objective means, postmortem accumulation of potassium in vitreous humor is a widely used gauge. In view of the considerable variability inherent in these techniques, an additional marker with greater accuracy would be a welcome supplement to these indices. We have developed a method of estimating PMI from the level of 3-methoxytyramine (3-MT) in the dorsal putamen of the brain. The supernatant of a sample of putamen, sonicated in 6 volumes (weight/volume) of 0.1 M perchloric acid and centrifuged at 51 000 times gravity for 10 min, was analyzed for 3-MT using high-pressure liquid chromatography with electrochemical detection. The change of 3-MT in the putamen is linearly related to the PMI (range: 5.5 to 60 h), irrespective of patient age (1 to 84 years). This observation is attributable to several factors, including high substrate (dopamine) concentration, preservation of catechol-O-methyl transferase activity, and an inactivation of monoamine oxidase activity, as a result of a decrease in tissue pO2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734746

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  2 in total

1.  Postmortomics: The Potential of Untargeted Metabolomics to Highlight Markers for Time Since Death.

Authors:  Bogumila K Pesko; Stefan Weidt; Mark McLaughlin; Daniel J Wescott; Hazel Torrance; Karl Burgess; Richard Burchmore
Journal:  OMICS       Date:  2020-10-13

Review 2.  Applications of Metabolomics in Forensic Toxicology and Forensic Medicine.

Authors:  Michal Szeremeta; Karolina Pietrowska; Anna Niemcunowicz-Janica; Adam Kretowski; Michal Ciborowski
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.